<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00800657</url>
  </required_header>
  <id_info>
    <org_study_id>HFRCTC1</org_study_id>
    <secondary_id>HFRCTC1</secondary_id>
    <nct_id>NCT00800657</nct_id>
  </id_info>
  <brief_title>Stem Cells and Resynchronization Cardiac</brief_title>
  <acronym>RCT and SCT</acronym>
  <official_title>Stem-Cells and Heart Failure in Several Ethiologies. Alternative Indication With Cardiac Resynchronization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Molestias Cardiovasculares</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Molestias Cardiovasculares</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Same patients with dilated myocardiopathies with large areas of fibrosis has not been as
      successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional
      class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant
      with Cardiac Resynchronization Therapy in these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About 120cc of blood are collected from the iliac bone marrow under epidural anesthesia.In
      the cell therapy lab this blood is harvested and mononuclear cells are separated.This
      procedure takes roughly 4 hours.After dilution the mononuclear cells are injected into the
      cardiac muscles with fibroses area through 20 shots.This procedure is indicated for patients
      with cardiac ischemia and left ventricular dysfunction(desynchrony), on whom all the others
      known therapies have failed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ejection Fraction(EF)-(Eco- Sympson):It is the comparison of these measurements between late pre and post operative. NYHA: Comparison of these measurements between late pre and post operative.</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ejection Fraction (Echo/Sympson) and functional class(NYHA).</measure>
    <time_frame>24 months.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pacing and Stem Cells Implantations.</intervention_name>
    <description>Implantation of Cardiac Ressyncrhonization combined with the implantation of Stem Cells Hematopoietics.</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pacing and Stem Cells Implantation</intervention_name>
    <description>Pacing and Stem Cells Implantation.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Dilated Cardiomyopathy

          -  Heart Failure

          -  Optimized Therapeutics

          -  Ventricular Desynchrony

          -  Functional Class III or IV

          -  Ejection Fraction(Echo/ Sympson) &lt; 35%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oswaldo Tadeu Greco, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMC - Institute of Hearth Diseases</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oswaldo Tadeu Greco, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMC- Institute of Hearth Diseases</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oswaldo Tadeu Greco, PhD</last_name>
    <phone>55-17-3203-4000</phone>
    <phone_ext>4038</phone_ext>
    <email>oswaldogreco@terra.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Carolina de Abreu, MD</last_name>
    <phone>55-17-7811-8477</phone>
    <email>carolina.cpc@terra.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Imc - Instituto de Moléstias Cardiovasculares</name>
      <address>
        <city>São José do Rio Preto</city>
        <state>São Paulo</state>
        <zip>15015-210</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oswaldo Tadeu Greco, PhD</last_name>
      <phone>55-17-3203-4000</phone>
      <phone_ext>4038</phone_ext>
      <email>oswaldogreco@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Oswaldo Tadeu Greco, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://deca.org.br</url>
    <description>Departamento de Estimulação Cardiaca e Arritmia.</description>
  </link>
  <link>
    <url>http://imconline.com.br</url>
    <description>IMC-Instituto de Moléstias Cardiovasculares</description>
  </link>
  <results_reference>
    <citation>Jacob JL, Salis FV, Ruiz MA, Greco OT. Labeled stem cells transplantation to the myocardium of a patient with Chagas' disease. Arq Bras Cardiol. 2007 Aug;89(2):e10-1. English, Portuguese.</citation>
    <PMID>17874006</PMID>
  </results_reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2008</study_first_submitted>
  <study_first_submitted_qc>December 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2008</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Oswaldo Tadeu Greco</name_title>
    <organization>IMC - Instituto de Moléstias Cardiovasculares</organization>
  </responsible_party>
  <keyword>Cardiac Resynchronization</keyword>
  <keyword>Dilated Cardiomyopathy</keyword>
  <keyword>Stem Cells Therapy</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Stem Cells/Cardiac Pacing, Artificial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

